The cost-effectiveness of Palivizumab in Austria

被引：1
|
作者：
Resch, B
Nuijten, MJ
Lebmeier, M
Wittenberg, W
Gusenleitner, W
机构：
[1] Graz Univ, Graz, Austria
[2] Erasmus Univ, Jisp, Ars Accessus Medica, Amsterdam, Netherlands
[3] Univ Sheffield, Sheffield, S Yorkshire, England
[4] Abbott GmbH & Co KG, Ludwigshafen, AL, Germany
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64598-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A94 / A94
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness model of palivizumab in the UK
    Nuijten, MJ
    Lebmeier, M
    Wittenberg, W
    VALUE IN HEALTH, 2005, 8 (06) : A62 - A62
  • [2] Cost-effectiveness of palivizumab in New Zealand
    Vogel, AM
    McKinlay, MJ
    Ashton, T
    Lennon, DR
    Harding, JE
    Pinnock, R
    Graham, D
    Grimwood, K
    Pattemore, PK
    Schousboe, M
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2002, 38 (04) : 352 - 357
  • [3] Cost-effectiveness model of Palivizumab in The Netherlands
    Nuijten, MJ
    Lebmeier, M
    Daalderop, P
    Wittenberg, W
    VALUE IN HEALTH, 2005, 8 (06) : A52 - A52
  • [4] Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria
    Resch, Bernhard
    Gusenleitner, Walter
    Nuijten, Mark J. C.
    Lebmeier, Maximilian
    Wittenberg, Wolfgang
    CLINICAL THERAPEUTICS, 2008, 30 (04) : 749 - 760
  • [5] A review of cost-effectiveness of palivizumab for respiratory syncytial virus
    Hussman, Julia M.
    Li, Abby
    Paes, Bosco
    Lanctot, Krista L.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (05) : 553 - 567
  • [6] Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab
    Reeve, Carole A.
    Whitehall, John S.
    Buettner, Petra G.
    Norton, Robert
    Reeve, David M.
    Francis, Fleur
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2006, 42 (05) : 253 - 258
  • [7] Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab
    Mahadevia, Parthiv J.
    Malinoski, Frank J.
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2007, 161 (05): : 519 - 520
  • [8] COST-EFFECTIVENESS OF PALIVIZUMAB IN CHILDREN WITH CONGENITAL HEART DISEASE IN SPAIN
    Grubb, E.
    Garcia, N.
    Rivas-Basterra, A.
    Majer, I.
    Medrano, C.
    Schmidt, R.
    EUROPEAN JOURNAL OF PEDIATRICS, 2016, 175 (11) : 1812 - 1813
  • [9] Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus: A Systematic Review
    Mac, Stephen
    Sumner, Amanda
    Duchesne-Belanger, Samuel
    Stirling, Robert
    Tunis, Matthew
    Sander, Beate
    PEDIATRICS, 2019, 143 (05)
  • [10] COST-EFFECTIVENESS OF PALIVIZUMAB IN CHILDREN WITH CONGENITAL HEART DISEASE IN MEXICO
    Majer, I
    Pichardo-Pina, C. A.
    Sanchez-Casillas, J. L.
    Schmidt, R.
    Vo, P.
    VALUE IN HEALTH, 2015, 18 (07) : A830 - A830
12345